A Phase 1, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Local Administration of EXPAREL for Postsurgical Analgesia in Pediatric Subjects 12 to Less Than 17 Years of Age
Phase of Trial: Phase I
Latest Information Update: 03 Aug 2018
At a glance
- Drugs Bupivacaine (Primary)
- Indications Postoperative pain
- Focus Pharmacokinetics
- Sponsors Pacira Pharmaceuticals
- 24 Jul 2018 Planned primary completion date changed from 30 Jun 2018 to 30 Aug 2018.
- 24 Jul 2018 Status changed from not yet recruiting to recruiting.
- 04 Apr 2018 New trial record